期刊文献+

B cell infiltration is highly associated with prognosis and an immune-infiltrated tumor microenvironment in neuroblastoma

原文传递
导出
摘要 Aim:Neuroblastoma is the most common extracranial solid tumor in children.Recent advances in immunotherapy Approaches,including in neuroblastoma,have shown the important role of the immune system in mounting an effective anti-tumor response.In this study,we aimed to provide a comprehensive investigation of immune cell infiltration in neuroblastoma utilizing a large number of gene expression datasets.Methods:We inferred immune cell infiltration using an established immune inference method and evaluated the association between immune cell abundance and patient prognosis as well as common chromosomal abnormalities found in neuroblastoma.In addition,we evaluated co-infiltration patterns among distinct immune cell types.Results:The infiltration of naïve B cells,NK cells,and CD8+T cells was associated with improved patient prognosis.Naïve B cells were the most consistent indicator of prognosis and associated with an active immune tumor microenvironment.Patients with high B cell infiltration showed high co-infiltration of other immune cell types and the enrichment of immune-related pathways.The presence of high B cell infiltration was associated with both recurrence-free and overall survival,even after adjusting for clinical variables.Conclusion:In this study,we have provided a comprehensive evaluation of immune cell infiltration in neuroblastoma using gene expression data.We propose an important role for B cells in the neuroblastoma tumor microenvironment and suggest that B cells can be used as a prognostic biomarker to predict recurrence-free and overall survival independently of currently utilized prognostic variables.
出处 《Journal of Cancer Metastasis and Treatment》 2021年第1期466-477,共12页 癌症转移与治疗(英文版)
基金 supported by the Cancer Prevention Research Institute of Texas(CPRIT)(RR180061 to Cheng C) the National Cancer Institute of the National Institutes of Health(1R21CA227996 to Cheng C) the T32 training grant of the National Institutes of Health(T32 AI007363 to Schaafsma E).Cheng C is a CPRIT Scholar in Cancer Research.
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部